Aurinia Pharmaceuticals, Inc. (AUPH)
13.95
-0.42
(-2.92%)
USD |
NASDAQ |
Mar 13, 16:00
13.95
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Market Cap : 1.855B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xenon Pharmaceuticals, Inc. | 4.595B |
| Oncolytics Biotech, Inc. | 105.88M |
| Edesa Biotech, Inc. | 49.67M |
| Lexaria Bioscience Corp. | 17.42M |
| ProMIS Neurosciences, Inc. | 39.07M |
Market Cap Related Metrics
| PE Ratio | 6.716 |
| PS Ratio | 6.837 |
| PEG Ratio | 0.0013 |
| Price to Book Value | 3.191 |
| Price to Free Cash Flow | 14.26 |
| Price | 13.95 |
| Earnings Yield | 14.89% |
| PEGY Ratio | 0.0013 |
| Operating PE Ratio | 16.67 |
| Normalized PE Ratio | 6.69 |